Citius Oncology, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Citius Oncology, Inc. Share Price Chart

$0.00$0.00

Citius Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-0.34	Revenue (TTM) N/A	Return On Equity (TTM) -55.19%
Profit Margin N/A	Debt to Equity 1.10	Quarterly Earnings Growth YoY 16.90%

Citius Oncology, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Dec 2024	Mar 2025	Jun 2025	Dec 2025
Revenue	N/A	N/A	N/A	N/A	N/A	$3.94M
Net Profit	$489829.00	$252462.00	-$6.66M	-$7.74M	-$5.37M	-$5.53M
Net Profit Margin	N/A	N/A	N/A	N/A	N/A	-140.31%
Income Change	N/A	-48.46%	-2737.71%	-16.16%	30.58%	-3.06%

Citius Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2025
Revenue	N/A	N/A	N/A
Net Profit	$380811.00	$2.42M	-$24.76M
Net Profit Margin	N/A	N/A	N/A
Income Change	N/A	535.30%	-1123.49%

About Citius Oncology, Inc.

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Citius Oncology, Inc. Historical Returns

Month	Open	Close	Change %

CTOR Share Price FAQs

What is Citius Oncology, Inc. share price today?

Citius Oncology, Inc. share price today is $0.00 as on August 9, 2026 at 11:10 am IST.

What is the 52 week high and 52 week low of Citius Oncology, Inc. stock?

52 week high/low data for Citius Oncology, Inc. is currently unavailable.

What is CTOR's net income for the last quarter?

CTOR's net income for the last quarter is -0.01B USD.

Can I buy CTOR shares in India?

Yes. You can buy CTOR in India by opening an international trading account.